Amphastar Announces FDA Approval for Teriparatide Injection [Yahoo! Finance]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Yahoo! Finance
Food and Drug Administration ("FDA") has approved the Company's Abbreviated New Drug Application ("ANDA") for teriparatide injection, USP 560 mcg/2.24mL (250 mcg/mL) single-patient-use prefilled pen. The FDA determined that Amphastar's teriparatide is bioequivalent and therapeutically equivalent to Eli Lilly's FORTEO ® "We are proud to announce FDA approval of Amphastar's first-ever pen device combination product, demonstrating our continued commitment to advancing innovative approaches for complex drug delivery mechanisms," said Dr. Jack Zhang, Amphastar's President and Chief Executive Officer. "Our teriparatide drug product is bioequivalent and therapeutically equivalent to Eli Lilly's FORTEO ® , providing patients confidence in its reliability and effectiveness, while offering a thoughtfully designed, easy-to-use, and affordable option for managing daily osteoporosis therapy. Manufactured entirely in-house, with the drug product manufactured at our U.S. facility, we offer a depen
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- IQVIA (NYSE:IQV) was given a new $230.00 price target on by analysts at Barclays PLC.MarketBeat
- Electronic Clinical Outcome Assessment Solutions Market Projected to Reach USD 5.64 Billion by 2032 at a CAGR of 15.3% - SNS Insider [Yahoo! Finance]Yahoo! Finance
- Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here's what to know [CNBC]CNBC
- IQVIA: Increasingly Indispensable In Drug Development [Seeking Alpha]Seeking Alpha
- Moderna (MRNA) Q3 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 10/28/25 - Beat
IQV
Sec Filings
- 12/9/25 - Form 8-K
- 11/14/25 - Form 3
- 11/7/25 - Form 4
- IQV's page on the SEC website